Falcon Point Capital’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Falcon Point Capital’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-9,679	Closed	-$849K	–	126
2018 Q1	$849K	Sell	9,679 -2,055	-18%	-$188K	0.17%	76
2017 Q4	$996K	Sell	11,734 -9,336	-44%	-$782K	0.17%	74
2017 Q3	$1.76M	Sell	21,070 -1,032	-5%	-$82.7K	0.26%	61
2017 Q2	$1.71M	Sell	22,102 -4,568	-17%	-$324K	0.23%	65
2017 Q1	$1.85M	Buy	26,670 +819	+3%	+$55K	0.25%	61
2016 Q4	$1.53M	Buy	25,851 +770	+3%	+$47.5K	0.2%	63
2016 Q3	$1.41M	Buy	25,081 +2,229	+10%	+$138K	0.22%	63
2016 Q2	$1.24M	Buy	22,852 +2,552	+13%	+$140K	0.21%	70
2016 Q1	$1.05M	Buy	20,300 +2,268	+13%	+$118K	0.18%	75
2015 Q4	$1.27M	Buy	18,032 +1,217	+7%	+$83K	0.27%	62
2015 Q3	$1.05M	Sell	16,815 -3,750	-18%	-$296K	0.37%	69
2015 Q2	$1.73M	Sell	20,565 -72	-0.3%	-$5.6K	0.58%	53
2015 Q1	$1.55M	Buy	20,637 +162	+0.8%	+$11.3K	1.21%	31
2014 Q4	$1.27M	Buy	20,475 +3,192	+18%	+$182K	1.17%	33
2014 Q3	$899K	Buy	+17,283	New	+$881K	0.76%	52

Other funds holding XBI

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return

Falcon Point Capital's XBI Position: Q2 2018 in Review

Falcon Point Capital sold out of State Street SPDR S&P Biotech ETF (XBI) in Q2 2018, closing a stake of 9,679 shares — an estimated $849K sold.

Falcon Point Capital first reported a position in XBI in Q3 2014 and held it in 15 quarters. The position peaked at $1.85M in Q1 2017. 430 funds tracked by Wall St. Rank hold XBI as of Q2 2018.

Falcon Point Capital reported no remaining State Street SPDR S&P Biotech ETF position as of Q2 2018 after selling out during the quarter.
Falcon Point Capital sold 9,679 State Street SPDR S&P Biotech ETF shares in Q2 2018, an estimated $849K.
Falcon Point Capital first reported a position in State Street SPDR S&P Biotech ETF in Q3 2014 and held it in 15 quarters.
Falcon Point Capital's State Street SPDR S&P Biotech ETF position peaked at $1.85M in Q1 2017.
430 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2018.

Based on Falcon Point Capital's 13F filing for Q2 2018, filed 7 Aug 2018.